Clinical update in optic nerve disorders

References

• Tosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol 2014;13(1):83-99
   PubMed Web of Science ®Google Scholar
• Hayreh SS. Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management. Eye Lond Engl 1990;4(Pt 1):25-41
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998;125(4):509-20
   PubMed Web of Science ®Google Scholar
• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90(3):262-7
   PubMed Web of Science ®Google Scholar
• Tham Y-C, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014;121(11):2081-90
   PubMed Web of Science ®Google Scholar
• Chinnery PF, Johnson MA, Wardell TM, et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 2000;48(2):188-93
   PubMed Web of Science ®Google Scholar
• Lam BL, Feuer WJ, Abukhalil F, et al. Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1. Arch Ophthalmol 2010;128(9):1129-35
   PubMedGoogle Scholar
• Kjer B, Eiberg H, Kjer P, et al. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand 1996;74(1):3-7
   PubMedGoogle Scholar
• Guy J, Qi X, Koilkonda RD, et al. Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system. Invest Ophthalmol Vis Sci 2009;50(9):4205-14
   PubMed Web of Science ®Google Scholar
• Bainbridge JWB, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med 2008;358(21):2231-9
   PubMed Web of Science ®Google Scholar
• Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA 2008;105(39):15112-17
   PubMed Web of Science ®Google Scholar
• Simonelli F, Maguire AM, Testa F, et al. Gene Therapy for Leber’s Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration. Mol Ther 2010;18(3):643-50
   PubMed Web of Science ®Google Scholar
• Cideciyan AV, Jacobson SG, Beltran WA, et al. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci USA 2013;110(6):E517-25
   PubMed Web of Science ®Google Scholar
• MacLaren RE, Groppe M, Barnard AR, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet 2014;383(9923):1129-37
   PubMed Web of Science ®Google Scholar
• Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients. Available from: https://clinicaltrials. gov/ct2/show/NCT02064569
   Google Scholar
• Boomer JA, Siatkowski RM. Optic neuritis in adults and children. Semin Ophthalmol 2003;18(4):174-80
   PubMedGoogle Scholar
• Gundogan F, Tas A, Oz O, et al. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis. Indian J Ophthalmol 2013;61(3):100
   PubMed Web of Science ®Google Scholar
• The clinical profile of optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 1991;109(12):1673-8
   PubMedGoogle Scholar
• Fazzone HE, Lefton DR, Kupersmith MJ. Optic neuritis: correlation of pain and magnetic resonance imaging. Ophthalmology 2003;110(8):1646-9
   PubMed Web of Science ®Google Scholar
• Guthrie TC, Nelson DA. Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci 1995;129(1):1-8
   PubMed Web of Science ®Google Scholar
• Diaper CJ. Pulfrich revisited. Surv Ophthalmol 1997;41(6):493-9
   PubMed Web of Science ®Google Scholar
• Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. The Lancet 2008;372(9634):234-45
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998;125(4):521-6
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Podhajsky PA, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 1997;124(5):641-7
   PubMed Web of Science ®Google Scholar
• Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996;114(11):1366-74
   PubMedGoogle Scholar
• Miller NR, Arnold AC. Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye Lond Engl 2014. [Epub ahead of print]
   Google Scholar
• Repka MX, Savino PJ, Schatz NJ, et al. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983;96(4):478-83
   PubMed Web of Science ®Google Scholar
• Mojon DS, Hedges TR, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2002;120(5):601-5
   PubMedGoogle Scholar
• Palombi K, Renard E, Levy P, et al. Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol 2006;90(7):879-82
   PubMed Web of Science ®Google Scholar
• Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134(3):317-28
   PubMed Web of Science ®Google Scholar
• Ramakrishan R, Krishnadas R, Robin AL, et al. Diagnosis and Management of Glaucoma. JP Medical Ltd; 2013. p. 682
   Google Scholar
• Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989;107(5):453-64
   PubMed Web of Science ®Google Scholar
• Denis P, Lafuma A, Berdeaux G. Medical predictive factors of glaucoma treatment costs. J Glaucoma 2004;13(4):283-90
   PubMed Web of Science ®Google Scholar
• Nduaguba C, Lee RK. Glaucoma screening: current trends, economic issues, technology, and challenges. Curr Opin Ophthalmol 2006;17(2):142-52
   PubMed Web of Science ®Google Scholar
• Maul EA, Jampel HD. Glaucoma screening in the real world. Ophthalmology 2010;117(9):1665-6
   PubMed Web of Science ®Google Scholar
• Fan BJ, Liu K, Wang DY, et al. Association of polymorphisms of tumor necrosis factor and tumor protein p53 with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2010;51(8):4110-16
   PubMed Web of Science ®Google Scholar
• Stone EM, Fingert JH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. Science 1997;275(5300):668-70
   PubMed Web of Science ®Google Scholar
• Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002;295(5557):1077-9
   PubMed Web of Science ®Google Scholar
• Hauser MA, Allingham RR, Linkroum K, et al. Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2006;47(6):2542-6
   PubMed Web of Science ®Google Scholar
• Fan BJ, Wang DY, Lam DSC, et al. Gene mapping for primary open angle glaucoma. Clin Biochem 2006;39(3):249-58
   PubMed Web of Science ®Google Scholar
• Wiggs JL, Allingham RR, Vollrath D, et al. Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma. Am J Hum Genet 1998;63(5):1549-52
   PubMed Web of Science ®Google Scholar
• Fingert JH, Héon E, Liebmann JM, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 1999;8(5):899-905
   PubMed Web of Science ®Google Scholar
• Aung T, Rezaie T, Okada K, et al. Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest Ophthalmol Vis Sci 2005;46(8):2816-22
   PubMed Web of Science ®Google Scholar
• Thorleifsson G, Walters GB, Hewitt AW, et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet 2010;42(10):906-9
   PubMed Web of Science ®Google Scholar
• Fan BJ, Wang DY, Pasquale LR, et al. Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population. Invest Ophthalmol Vis Sci 2011;52(3):1788-92
   PubMed Web of Science ®Google Scholar
• Writing Committee for the Normal Tension Glaucoma Genetic Study Group of Japan Glaucoma Society. Meguro A, Inoko H, Ota M, et al. Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology. 2010;117(7):1331-8. e5
   Google Scholar
• Brown MD. The enigmatic relationship between mitochondrial dysfunction and Leber’s hereditary optic neuropathy. J Neurol Sci 1999;165(1):1-5
   PubMed Web of Science ®Google Scholar
• Sadun A. Acquired mitochondrial impairment as a cause of optic nerve disease. Trans Am Ophthalmol Soc 1998;96:881-923
   PubMedGoogle Scholar
• Sadun AA, Win PH, Ross-Cisneros FN, et al. Leber’s hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc 2000;98:223-32. discussion 232-5
   PubMedGoogle Scholar
• Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 2002;40(6):573-84
   PubMed Web of Science ®Google Scholar
• Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 1996;59(2):481-5
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Griffiths PG, Hudson G, et al. Inherited mitochondrial optic neuropathies. J Med Genet 2009;46(3):145-58
   PubMed Web of Science ®Google Scholar
• Ji Y, Jia X, Li S, et al. Evaluation of the X-linked modifier loci for Leber hereditary optic neuropathy with the G11778A mutation in Chinese. Mol Vis 2010;16:416-24
   PubMed Web of Science ®Google Scholar
• Shankar SP, Fingert JH, Carelli V, et al. Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy. Ophthalmic Genet 2008;29(1):17-24
   PubMed Web of Science ®Google Scholar
• Bu XD, Rotter JI. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci USA 1991;88(18):8198-202
   PubMed Web of Science ®Google Scholar
• Hudson G, Carelli V, Spruijt L, et al. Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 2007;81(2):228-33
   PubMed Web of Science ®Google Scholar
• Riordan-Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber’s hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain J Neurol 1995;118(Pt 2):319-37
   Google Scholar
• Spruijt L, Kolbach DN, de Coo RF, et al. Influence of mutation type on clinical expression of Leber hereditary optic neuropathy. Am J Ophthalmol 2006;141(4):676-82
   PubMed Web of Science ®Google Scholar
• Delettre C, Lenaers G, Pelloquin L, et al. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab 2002;75(2):97-107
   PubMed Web of Science ®Google Scholar
• Ferré M, Bonneau D, Milea D, et al. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum Mutat 2009;30(7):E692-705
   Web of Science ®Google Scholar
• Reynier P, Amati-Bonneau P, Verny C, et al. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet 2004;41(9):e110
   Web of Science ®Google Scholar
• Kerrison JB, Arnould VJ, Ferraz Sallum JM, et al. Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12.2-12.3. Arch Ophthalmol 1999;117(6):805-10
   PubMedGoogle Scholar
• Barbet F, Hakiki S, Orssaud C, et al. A third locus for dominant optic atrophy on chromosome 22q. J Med Genet 2005;42(1):e1
   PubMed Web of Science ®Google Scholar
• Carelli V, Schimpf S, Fuhrmann N, et al. A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16. Hum Mol Genet 2011;20(10):1893-905
   PubMed Web of Science ®Google Scholar
• Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000;26(2):211-15
   PubMed Web of Science ®Google Scholar
• Zanna C, Ghelli A, Porcelli AM, et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain J Neurol 2008;131(Pt 2):352-67
   Google Scholar
• Olichon A, Landes T, Arnauné-Pelloquin L, et al. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J Cell Physiol 2007;211(2):423-30
   PubMed Web of Science ®Google Scholar
• Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes. Brain J Neurol 2008;131(Pt 2):338-51
   Google Scholar
• Amati-Bonneau P, Odent S, Derrien C, et al. The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene. Am J Ophthalmol 2003;136(6):1170-1
   PubMed Web of Science ®Google Scholar
• Amati-Bonneau P, Guichet A, Olichon A, et al. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol 2005;58(6):958-63
   PubMed Web of Science ®Google Scholar
• Hudson G, Amati-Bonneau P, Blakely EL, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain J Neurol 2008;131(Pt 2):329-37
   Google Scholar
• Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 2008;115(2):298-305.e2
   PubMed Web of Science ®Google Scholar
• Chan JW. Optic Nerve Disorders: Diagnosis and Management. 2010 edition Springer; New York: 2010. p. 284
   Google Scholar
• Behbehani R. Clinical approach to optic neuropathies. Clin Ophthalmol Auckl NZ 2007;1(3):233-46
   PubMedGoogle Scholar
• Schneck ME, Haegerstrom-Portnoy G. Color vision defect type and spatial vision in the optic neuritis treatment trial. Invest Ophthalmol Vis Sci 1997;38(11):2278-89
   PubMed Web of Science ®Google Scholar
• Van Diemen HAM, Lanting P, Koetsier JC, et al. Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests. Clin Neurol Neurosurg 1992;94(3):191-5
   PubMed Web of Science ®Google Scholar
• Papaconstantinou D, Georgalas I, Kalantzis G, et al. Acquired color vision and visual field defects in patients with ocular hypertension and early glaucoma. Clin Ophthalmol Auckl NZ 2009;3:251-7
   PubMedGoogle Scholar
• Quiros PA, Torres RJ, Salomao S, et al. Colour vision defects in asymptomatic carriers of the Leber’s hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study. Br J Ophthalmol 2006;90(2):150-3
   PubMed Web of Science ®Google Scholar
• Smith DP. Diagnostic criteria in cominantly inherited juvenile optic atrophy. A report of three new families. Am J Optom Arch Am Acad Optom 1972;49(3):183-200
   PubMedGoogle Scholar
• Kline LB, Glaser JS. Dominant optic atrophy. The clinical profile. Arch Ophthalmol 1979;97(9):1680-6
   PubMedGoogle Scholar
• Votruba M, Fitzke FW, Holder GE, et al. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol 1998;116(3):351-8
   PubMedGoogle Scholar
• Puomila A, Huoponen K, Mäntyjärvi M, et al. Dominant optic atrophy: correlation between clinical and molecular genetic studies. Acta Ophthalmol Scand 2005;83(3):337-46
   PubMedGoogle Scholar
• Wilhelm H. Neuro-ophthalmology of pupillary function–practical guidelines. J Neurol 1998;245(9):573-83
   PubMed Web of Science ®Google Scholar
• Bremner FD. Pupil assessment in optic nerve disorders. Eye 2004;18(11):1175-81
   PubMed Web of Science ®Google Scholar
• Lagrèze WD, Kardon RH. Correlation of relative afferent pupillary defect and estimated retinal ganglion cell loss. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Für Klin Exp Ophthalmol 1998;236(6):401-4
   PubMed Web of Science ®Google Scholar
• Wakakura M, Yokoe J. Evidence for preserved direct pupillary light response in Leber’s hereditary optic neuropathy. Br J Ophthalmol 1995;79(5):442-6
   PubMed Web of Science ®Google Scholar
• Nikoskelainen EK, Huoponen K, Juvonen V, et al. Ophthalmologic findings in leber hereditary optic neuropathy, with special reference to mtDNA Mutations. Ophthalmology 1996;103(3):504-14
   PubMed Web of Science ®Google Scholar
• Bremner FD, Shallo–Hoffmann J, Riordan–Eva P, et al. Comparing Pupil Function with Visual Function in Patients with Leber’s Hereditary Optic Neuropathy. Invest Ophthalmol Vis Sci 1999;40(11):2528-34
   PubMed Web of Science ®Google Scholar
• Chew SSL, Cunnningham WJ, Gamble GD, et al. Retinal nerve fiber layer loss in glaucoma patients with a relative afferent pupillary defect. Invest Ophthalmol Vis Sci 2010;51(10):5049-53
   PubMed Web of Science ®Google Scholar
• Tatham AJ, Meira-Freitas D, Weinreb RN, et al. Estimation of Retinal Ganglion Cell Loss in Glaucomatous Eyes With a Relative Afferent Pupillary Defect. Invest Ophthalmol Vis Sci 2014;55(1):513-22
   PubMed Web of Science ®Google Scholar
• Lankaranian D, Altangerel U, Spaeth GL, et al. The usefulness of a new method of testing for a relative afferent pupillary defect in patients with ocular hypertension and glaucoma. Trans Am Ophthalmol Soc 2005;103:200-8
   PubMedGoogle Scholar
• Kalaboukhova L, Fridhammar V, Lindblom B. Relative afferent pupillary defect in glaucoma: a pupillometric study. Acta Ophthalmol Scand 2007;85(5):519-25
   PubMedGoogle Scholar
• Kankipati L, Girkin CA, Gamlin PD. The Post-Illumination Pupil Response Is Reduced in Glaucoma Patients. Invest Ophthalmol Vis Sci 2011;52(5):2287-92
   PubMed Web of Science ®Google Scholar
• Feigl B, Mattes D, Thomas R, Zele AJ. Intrinsically Photosensitive (Melanopsin) Retinal Ganglion Cell Function in Glaucoma. Invest Ophthalmol Vis Sci 2011;52(7):4362-7
   PubMed Web of Science ®Google Scholar
• Piette SD, Sergott RC. Pathological optic-disc cupping. Curr Opin Ophthalmol 2006;17(1):1-6
   PubMed Web of Science ®Google Scholar
• Zhang Y-X, Huang H-B, Wei S-H. Clinical characteristics of nonglaucomatous optic disc cupping. Exp Ther Med 2014;7(4):995-9
   PubMed Web of Science ®Google Scholar
• Gerling J, Meyer JH, Kommerell G. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Für Klin Exp Ophthalmol 1998;236(3):188-92
   PubMed Web of Science ®Google Scholar
• Newman NJ, Biousse V, Newman SA, et al. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial. Am J Ophthalmol 2006;141(6):1061-7
   PubMed Web of Science ®Google Scholar
• Miller NR, Walsh FB, Hoyt WF. Walsh and Hoyt’s Clinical Neuro-ophthalmology. Lippincott Williams & Wilkins; 2005. p. 1404
   Google Scholar
• Kupersmith MJ, Mandel G, Anderson S, et al. Baseline, one and three month changes in the peripapillary retinal nerve fiber layer in acute optic neuritis: relation to baseline vision and MRI. J Neurol Sci 2011;308(1-2):117-23
   PubMed Web of Science ®Google Scholar
• Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006;113(2):324-32
   PubMed Web of Science ®Google Scholar
• Pollet-Villard F, Chiquet C, Romanet J-P, et al. Structure-function relationships with spectral-domain optical coherence tomography retinal nerve fiber layer and optic nerve head measurements. Invest Ophthalmol Vis Sci 2014;55(5):2953-62
   PubMed Web of Science ®Google Scholar
• Walter SD, Ishikawa H, Galetta KM, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 2012;119(6):1250-7
   PubMed Web of Science ®Google Scholar
• Syc SB, Saidha S, Newsome SD, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain J Neurol 2012;135(Pt 2):521-33
   Google Scholar
• Zhang Y, Huang H, Wei S, et al. Characterization of retinal nerve fiber layer thickness changes associated with Leber’s hereditary optic neuropathy by optical coherence tomography. Exp Ther Med 2014;7(2):483-7
   PubMed Web of Science ®Google Scholar
• Barboni P, Savini G, Parisi V, et al. Retinal nerve fiber layer thickness in dominant optic atrophy measurements by optical coherence tomography and correlation with age. Ophthalmology 2011;118(10):2076-80
   PubMed Web of Science ®Google Scholar
• Park SW, Hwang J-M. Optical coherence tomography shows early loss of the inferior temporal quadrant retinal nerve fiber layer in autosomal dominant optic atrophy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 2014; Epub ahead of print
   Google Scholar
• Barboni P, Savini G, Cascavilla ML, et al. Early macular retinal ganglion cell loss in dominant optic atrophy: genotype-phenotype correlation. Am J Ophthalmol 2014;158(3):628-36.e3
   PubMed Web of Science ®Google Scholar
• Hedges TR, Vuong LN, Gonzalez-Garcia AO, et al. Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography. Arch Ophthalmol 2008;126(6):812-15
   PubMedGoogle Scholar
• Youl BD, Turano G, Miller DH, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain J Neurol 1991;114(Pt 6):2437-50
   Web of Science ®Google Scholar
• Hickman SJ, Toosy AT, Miszkiel KA, et al. Visual recovery following acute optic neuritis–a clinical, electrophysiological and magnetic resonance imaging study. J Neurol 2004;251(8):996-1005
   PubMed Web of Science ®Google Scholar
• Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol 2012;11(2):157-69
   PubMed Web of Science ®Google Scholar
• Fay AM, Kane SA, Kazim M, et al. Magnetic resonance imaging of optic perineuritis. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 1997;17(4):247-9
   Web of Science ®Google Scholar
• Brown GC, Shields JA, Augsburger JJ, et al. Leukemic optic neuropathy. Int Ophthalmol 1981;3(2):111-16
   PubMed Web of Science ®Google Scholar
• Shimada Y, Shibuya M, Ohki R, et al. Bilateral optic neuropathy associated with multiple myeloma. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 2006;26(2):117-20
   Web of Science ®Google Scholar
• Matthews L, Enzinger C, Fazekas F, et al. MRI in Leber’s hereditary optic neuropathy: the relationship to multiple sclerosis. J Neurol Neurosurg Psychiatry 2014; Epub ahead of print
   Web of Science ®Google Scholar
• Normando EM, Turner LA, Cordeiro MF. The potential of annexin-labelling for the diagnosis and follow-up of glaucoma. Cell Tissue Res 2013;353(2):279-85
   PubMed Web of Science ®Google Scholar
• Khoobehi B, Beach JM, Kawano H. Hyperspectral imaging for measurement of oxygen saturation in the optic nerve head. Invest Ophthalmol Vis Sci 2004;45(5):1464-72
   PubMed Web of Science ®Google Scholar
• Mordant DJ, Al-Abboud I, Muyo G, et al. Oxygen saturation measurements of the retinal vasculature in treated asymmetrical primary open-angle glaucoma using hyperspectral imaging. Eye Lond Engl 2014;28(10):1190-200
   PubMed Web of Science ®Google Scholar
• Zhong Z, Petrig BL, Qi X, et al. In vivo measurement of erythrocyte velocity and retinal blood flow using adaptive optics scanning laser ophthalmoscopy. Opt Express 2008;16(17):12746-56
   PubMed Web of Science ®Google Scholar
• Takayama K, Ooto S, Hangai M, et al. High-resolution imaging of retinal nerve fiber bundles in glaucoma using adaptive optics scanning laser ophthalmoscopy. Am J Ophthalmol 2013;155(5):870-81
   PubMed Web of Science ®Google Scholar
• Beck RW, Cleary PA, Anderson MM, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326(9):581-8
   PubMed Web of Science ®Google Scholar
• Myles AB, Perera T, Ridley MG. Prevention of blindness in giant cell arteritis by corticosteroid treatment. Br J Rheumatol 1992;31(2):103-5
   PubMedGoogle Scholar
• González-Gay MA, Blanco R, Rodríguez-Valverde V, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998;41(8):1497-504
   PubMed Web of Science ®Google Scholar
• Nesher G, Rubinow A, Sonnenblick M. Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study. Clin Exp Rheumatol 1997;15(3):303-6
   PubMed Web of Science ®Google Scholar
• Delecoeuillerie G, Joly P, Cohen de Lara A, et al. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis 1988;47(9):733-9
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology 2003;110(6):1204-15
   PubMed Web of Science ®Google Scholar
• Chevalet P, Barrier JH, Pottier P, et al. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol 2000;27(6):1484-91
   PubMed Web of Science ®Google Scholar
• Mazlumzadeh M, Hunder GG, Easley KA, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 2006;54(10):3310-18
   PubMed Web of Science ®Google Scholar
• Alba MA, García-Martínez A, Prieto-González S, et al. Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. Medicine (Baltimore) 2014;93(5):194-201
   PubMed Web of Science ®Google Scholar
• Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120(6):701-13. discussion 829–30
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120(10):1268-79
   PubMed Web of Science ®Google Scholar
• EGS Guidelines. Internet Available from: www.eugs.org/eng/EGS_guidelines.Asp [cited 2014 Aug 15]
   Google Scholar
• Lee JWY, Gangwani RA, Chan JCH, Lai JS. Prospective study on the efficacy of treating normal tension glaucoma with a single session of selective laser trabeculoplasty. J Glaucoma 2015;24(1):77-80
   PubMed Web of Science ®Google Scholar
• Sayin N, Alkin Z, Ozkaya A, et al. Efficacy of selective laser trabeculoplasty in medically uncontrolled glaucoma. ISRN Ophthalmol 2013;2013:975281
   PubMedGoogle Scholar
• Brandão LM, Grieshaber MC. Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants. J Ophthalmol 2013;2013:705915
   PubMed Web of Science ®Google Scholar
• Fraser SG, Wormald RPL. Hospital Episode Statistics and changing trends in glaucoma surgery. Eye Lond Engl 2008;22(1):3-7
   PubMed Web of Science ®Google Scholar
• Whittaker KW, Gillow JT, Cunliffe IA. Is the role of trabeculectomy in glaucoma management changing? Eye Lond Engl 2001;15(Pt 4):449-52
   PubMedGoogle Scholar
• Anderson DR. Normal tension glaucoma study. collaborative normal tension glaucoma study. Curr Opin Ophthalmol 2003;14(2):86-90
   PubMedGoogle Scholar
• Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998;126(4):487-97
   PubMed Web of Science ®Google Scholar
• Charlson ME, de Moraes CG, Link A, et al. Nocturnal systemic hypotension increases the risk of glaucoma progression. Ophthalmology 2014;121(10):2004-12
   PubMed Web of Science ®Google Scholar
• Ramli N, Nurull BS, Hairi NN, et al. Low nocturnal ocular perfusion pressure as a risk factor for normal tension glaucoma. Prev Med 2013;57(Suppl):S47-9
   Google Scholar
• Kaiser HJ, Flammer J, Graf T, et al. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Für Klin Exp Ophthalmol 1993;231(12):677-80
   PubMed Web of Science ®Google Scholar
• Emre M, Orgül S, Gugleta K, et al. Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol 2004;88(5):662-6
   PubMed Web of Science ®Google Scholar
• Fuchsjäger-Mayrl G, Wally B, Georgopoulos M, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 2004;45(3):834-9
   PubMed Web of Science ®Google Scholar
• Bouhenni RA, Dunmire J, Sewell A, et al. Animal models of glaucoma. J Biomed Biotechnol 2012;2012:692609
   PubMedGoogle Scholar
• Carelli V, La Morgia C, Sadun A. Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options. Curr Opin Neurol 2013;26:52-8
   PubMed Web of Science ®Google Scholar
• Levkovitch-Verbin H. Animal models of optic nerve diseases. Eye Lond Engl 2004;18(11):1066-74
   PubMed Web of Science ®Google Scholar
• Veth KN, Willer JR, Collery RF, et al. Mutations in zebrafish lrp2 result in adult-onset ocular pathogenesis that models myopia and other risk factors for glaucoma. PLoS Genet 2011;7(2):e1001310
   Web of Science ®Google Scholar
• Ruiz-Ederra J, García M, Hernández M, et al. The pig eye as a novel model of glaucoma. Exp Eye Res 2005;81(5):561-9
   PubMed Web of Science ®Google Scholar
• Gupta A, Ding D, Lee RK, et al. Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a review. Invest Ophthalmol Vis Sci 2012;53(2):712-24
   PubMed Web of Science ®Google Scholar
• Asavapanumas N, Ratelade J, Papadopoulos MC, et al. Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G. J Neuroinflammation 2014;11:16
   PubMed Web of Science ®Google Scholar
• Grozdanic SD, Sakaguchi DS, Kwon YH, et al. Functional characterization of retina and optic nerve after acute ocular ischemia in rats. Invest Ophthalmol Vis Sci 2003;44(6):2597-605
   PubMed Web of Science ®Google Scholar
• Berkelaar M, Clarke DB, Wang YC, et al. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci Off J Soc Neurosci 1994;14(7):4368-74
   PubMed Web of Science ®Google Scholar
• Duvdevani R, Rosner M, Belkin M, et al. Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Restor Neurol Neurosci 1990;2(1):31-8
   PubMed Web of Science ®Google Scholar
• Touitou V, Johnson MA, Guo Y, et al. Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2013;54(12):7402-9
   PubMed Web of Science ®Google Scholar
• Zhang X, Jones D, Gonzalez-Lima F. Mouse model of optic neuropathy caused by mitochondrial complex I dysfunction. Neurosci Lett 2002;326(2):97-100
   PubMed Web of Science ®Google Scholar
• Lin CS, Sharpley MS, Fan W, et al. Mouse mtDNA mutant model of Leber hereditary optic neuropathy. Proc Natl Acad Sci USA 2012;109(49):20065-70
   PubMed Web of Science ®Google Scholar
• Yu H, Ozdemir SS, Koilkonda RD, et al. Mutant NADH dehydrogenase subunit 4 gene delivery to mitochondria by targeting sequence-modified adeno-associated virus induces visual loss and optic atrophy in mice. Mol Vis 2012;18:1668-83
   PubMed Web of Science ®Google Scholar
• Qi X, Sun L, Lewin AS, et al. The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse. Invest Ophthalmol Vis Sci 2007;48(1):1-10
   PubMed Web of Science ®Google Scholar
• Ellouze S, Augustin S, Bouaita A, et al. Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. Am J Hum Genet 2008;83(3):373-87
   PubMed Web of Science ®Google Scholar
• Hsu T-K, Wang A-G, Yen M-Y, et al. Leber’s hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery. Clin Exp Optom J Aust Optom Assoc 2014;97(1):84-6
   PubMed Web of Science ®Google Scholar
• Gurwood AS, Muchnick BG. The optic nerve in clinical practice. Butterworth-Heinemann; 1997. p. 260
   Google Scholar
• Rodriguez M, Siva A, Cross SA, et al. Optic neuritis: a population-based study in Olmsted county, Minnesota. Neurology 1995;45(2):244-50
   PubMed Web of Science ®Google Scholar
• Jin Y-P, de Pedro-Cuesta J, Söderström M, et al. Incidence of optic neuritis in Stockholm, Sweden 1990–1995: I. Age, sex, birth and ethnic-group related patterns. J Neurol Sci 1998;159(1):107-14
   PubMed Web of Science ®Google Scholar
• Wakakura M, Minei-Higa R, Oono S, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Jpn J Ophthalmol 1999;43(2):127-32
   PubMed Web of Science ®Google Scholar
• Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County. California. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 1994;14(1):38-44
   PubMed Web of Science ®Google Scholar
• Liu NH, LaBree LD, Feldon SE, et al. The epidemiology of giant cell arteritis: a 12-year retrospective study. Ophthalmology 2001;108(6):1145-9
   PubMed Web of Science ®Google Scholar
• Xu L, Wang Y, Jonas JB. Incidence of nonarteritic anterior ischemic optic neuropathy in adult Chinese: the Beijing Eye Study. Eur J Ophthalmol 2007;17(3):459-60
   PubMed Web of Science ®Google Scholar
• Lee MS, Grossman D, Arnold AC, et al. Incidence of Nonarteritic Anterior Ischemic Optic Neuropathy: increased Risk Among Diabetic Patients. Ophthalmology 2011;118(5):959-63
   PubMed Web of Science ®Google Scholar
• Preechawat P, Bruce BB, Newman NJ, et al. Anterior Ischemic Optic Neuropathy in Patients Younger than 50 Years. Am J Ophthalmol 2007;144(6):953-60
   PubMed Web of Science ®Google Scholar
• Schoff EO, Hattenhauer MG, Ing HH, et al. Estimated incidence of open-angle glaucoma in Olmsted County, Minnesota. Ophthalmology 2001;108(5):882-6
   PubMed Web of Science ®Google Scholar
• Leske M, Connell AS, Wu S, et al. Incidence of open-angle glaucoma: the Barbados eye studies. Arch Ophthalmol 2001;119(1):89-95
   PubMedGoogle Scholar
• Mukesh BN, McCarty CA, Rait JL, et al. Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 2002;109(6):1047-51
   PubMed Web of Science ®Google Scholar
• Puomila A, Hämäläinen P, Kivioja S, et al. Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet EJHG 2007;15(10):1079-89
   PubMed Web of Science ®Google Scholar
• Man PYW, Griffiths PG, Brown DT, et al. The Epidemiology of Leber Hereditary Optic Neuropathy in the North East of England. Am J Hum Genet 2003;72(2):333-9
   PubMed Web of Science ®Google Scholar
• Jia X, Li S, Xiao X, et al. Molecular epidemiology of mtDNA mutations in 903 Chinese families suspected with Leber hereditary optic neuropathy. J Hum Genet 2006;51(10):851-6
   PubMed Web of Science ®Google Scholar
• Macmillan C, Kirkham T, Fu K, et al. Pedigree analysis of French Canadian families with T14484C Leber’s hereditary optic neuropathy. Neurology 1998;50(2):417-22
   PubMed Web of Science ®Google Scholar
• Thiselton DL, Alexander C, Morris A, et al. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Hum Genet 2001;109(5):498-502
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Chinnery PF. Dominant optic atrophy: novel opa1 mutations and revised prevalence estimates. Ophthalmology 2013;120(8):1712-1712.e1
   PubMed Web of Science ®Google Scholar
• The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991;109(12):1673-8
   PubMedGoogle Scholar
• Melberg NS, Grand MG, Dieckert JP, et al. Cotton-wool spots and the early diagnosis of giant cell arteritis. Ophthalmology 1995;102(11):1611-14
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Für Klin Exp Ophthalmol 2007;245(8):1107-21
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Khaw PT. Primary open-angle glaucoma. The Lancet 2004;363(9422):1711-20
   PubMed Web of Science ®Google Scholar
• Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber’s hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 1991;111(6):750-62
   PubMed Web of Science ®Google Scholar
• Nikoskelainen E, Hoyt WF, Nummelin K. Ophthalmoscopic findings in Leber’s hereditary optic neuropathy. II. The fundus findings in the affected family members. Arch Ophthalmol 1983;101(7):1059-68
   PubMedGoogle Scholar
• Ortiz RG, Newman NJ, Manoukian SV, et al. Optic disk cupping and electrocardiographic abnormalities in an American pedigree with Leber’s hereditary optic neuropathy. Am J Ophthalmol 1992;113(5):561-6
   PubMed Web of Science ®Google Scholar
• Votruba M, Thiselton D, Bhattacharya SS. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy. Br J Ophthalmol 2003;87(1):48-53
   PubMed Web of Science ®Google Scholar
• Keltner JL, Johnson CA, Spurr JO, et al. Comparison of central and peripheral visual field properties in the optic neuritis treatment trial. Am J Ophthalmol 1999;128(5):543-53
   PubMed Web of Science ®Google Scholar
• Keltner JL, Johnson CA, Spurr JO, et al. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 1993;111(2):231-4
   PubMedGoogle Scholar
• Fakin A, Kerin V, Hawlina M. Visual fields in giant cell arteritis (Horton’s disease). Transl Neurosci 2011;2(4):325-30
   Web of Science ®Google Scholar
• Hayreh SS, Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol 2005;123(11):1554-62
   PubMedGoogle Scholar
• Montehermoso A, Cervera R, Font J, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum 1999;28(5):326-32
   PubMed Web of Science ®Google Scholar
• Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364(9451):2106-12
   PubMed Web of Science ®Google Scholar
• Weinstein JM, Lexow SS, Ho P, et al. Acute syphilitic optic neuritis. Arch Ophthalmol 1981;99(8):1392-5
   PubMedGoogle Scholar
• Azevedo AR, Simões R, Silva F, et al. Optic neuritis in an adult patient with chickenpox. Case Rep Ophthalmol Med 2012;2012:371584
   PubMedGoogle Scholar
• Siddiqui J, Rouleau J, Lee AG, et al. Bilateral optic neuritis in acute hepatitis C. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 2009;29(2):128-33
   PubMed Web of Science ®Google Scholar
• Jayaraman M, Gandhi RA, Ravi P, et al. Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy. Indian J Ophthalmol 2014;62(3):299-304
   PubMed Web of Science ®Google Scholar
• Weizer JS, Musch DC, Niziol LM, et al. Multifocal visual evoked potentials for early glaucoma detection. Ophthalmic Surg Lasers Imaging Off J Int Soc Imaging Eye 2012;43(4):335-40
   PubMedGoogle Scholar
• Gratton SM, Lam BL. Visual loss and optic nerve head swelling in thiamine deficiency without prolonged dietary deficiency. Clin Ophthalmol Auckl NZ 2014;8:1021-4
   PubMedGoogle Scholar
• Golnik KC, Schaible ER. Folate-responsive optic neuropathy. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 1994;14(3):163-9
   PubMed Web of Science ®Google Scholar
• Sadun AA, Martone JF, Muci-Mendoza R, et al. Epidemic optic neuropathy in Cuba. Eye findings. Arch Ophthalmol 1994;112(5):691-9
   PubMedGoogle Scholar
• Van Oostenbrugge RJ, Twijnstra A. Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology 1999;53(2):382-5
   PubMed Web of Science ®Google Scholar
• Goldsmith P, Jones RE, Ozuzu GE, et al. Optic neuropathy as the presenting feature of HIV infection: recovery of vision with highly active antiretroviral therapy. Br J Ophthalmol 2000;84(5):551-3
   PubMed Web of Science ®Google Scholar
• Modvig S, Degn M, Horwitz H, et al. Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis. PLoS One 2013;8(10):e77163
   PubMed Web of Science ®Google Scholar
• Schmidt RM, Kuppe G, Kissig B, et al. Research approaches on the diagnosis of multiple sclerosis by CSF examination. Schweiz Arch Für Neurol Psychiatr Zurich Switz 1985;138(3):13-22
   Google Scholar
• Lincoff NS, Erlich PD, Brass LS. Thrombocytosis in temporal arteritis rising platelet counts: a red flag for giant cell arteritis. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 2000;20(2):67-72
   Web of Science ®Google Scholar
• Costello F, Zimmerman MB, Podhajsky PA, et al. Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy. Eur J Ophthalmol 2004;14(3):245-57
   PubMed Web of Science ®Google Scholar
• Brittain GP, McIlwaine GG, Bell JA, et al. Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis? Br J Ophthalmol 1991;75(11):656-9
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Podhajsky PA, Raman R, et al. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123(3):285-96
   PubMed Web of Science ®Google Scholar
• Cavazza A, Muratore F, Boiardi L, et al. Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol 2014;38(10):1360-70
   PubMed Web of Science ®Google Scholar
• Breuer GS, Nesher R, Reinus K, et al. Association between histological features in temporal artery biopsies and clinical features of patients with giant cell arteritis. Isr Med Assoc J IMAJ 2013;15(6):271-4
   PubMed Web of Science ®Google Scholar
• Deramo VA, Sergott RC, Augsburger JJ, et al. Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology 2003;110(5):1041-6. discussion 1046
   PubMed Web of Science ®Google Scholar
• Pianka P, Almog Y, Man O, et al. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology 2000;107(8):1588-92
   PubMed Web of Science ®Google Scholar
• Pangeni G, Lämmer R, Tornow RP, et al. On- and off-response ERGs elicited by sawtooth stimuli in normal subjects and glaucoma patients. Doc Ophthalmol Adv Ophthalmol 2012;124(3):237-48
   PubMed Web of Science ®Google Scholar
• Forte R, Ambrosio L, Bonavolontà P, et al. Pattern electroretinogram optimized for glaucoma screening (PERGLA) and retinal nerve fiber thickness in suspected glaucoma and ocular hypertension. Doc Ophthalmol Adv Ophthalmol 2010;120(2):187-92
   PubMed Web of Science ®Google Scholar
• Chan C, Paine M, O’Day J. Steroid management in giant cell arteritis. Br J Ophthalmol 2001;85(9):1061-4
   PubMed Web of Science ®Google Scholar
• Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA 1995;273(8):625-32
   PubMed Web of Science ®Google Scholar
• Kinori M, Ben-Bassat I, Wasserzug Y, et al. Visual outcome of mega-dose intravenous corticosteroid treatment in non-arteritic anterior ischemic optic neuropathy - retrospective analysis. BMC Ophthalmol 2014;14:62
   PubMed Web of Science ®Google Scholar
• Rebolleda G, Pérez-López M, Casas-LLera P, et al. Visual and anatomical outcomes of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Für Klin Exp Ophthalmol 2013;251(1):255-60
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 2008;246(7):1029-46
   PubMed Web of Science ®Google Scholar
• Yaman A, Selver OB, et al. Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy. Clin Exp Optom J Aust Optom Assoc 2008;91(6):561-4
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA J Am Med Assoc 2014;311(18):1901-11
   PubMed Web of Science ®Google Scholar
• AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 2002;134(4):481-98
   PubMed Web of Science ®Google Scholar
• Wong MOM, Lee JWY, Choy BNK, et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol 2015;60(1):36-50
   PubMed Web of Science ®Google Scholar
• Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108(11):1943-53
   PubMed Web of Science ®Google Scholar
• Newman NJ, Biousse V, David R, et al. Prophylaxis for second eye involvement in Leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am J Ophthalmol 2005;140(3):407-15
   PubMed Web of Science ®Google Scholar
• Pfeffer G, Horvath R, Klopstock T, et al. New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol 2013;9(8):474-81
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Votruba M, Moore AT, et al. Treatment strategies for inherited optic neuropathies: past, present and future. Eye 2014;28(5):521-37
   PubMed Web of Science ®Google Scholar
• Krupin T, Liebmann JM, Greenfield DS, et al. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol 2011;151(4):671-81
   PubMed Web of Science ®Google Scholar
• Osborne NN. Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned. Acta Ophthalmol (Copenh) 2009;87(4):450-4
   PubMed Web of Science ®Google Scholar
• Quigley HA. Clinical trials for glaucoma neuroprotection are not impossible. Curr Opin Ophthalmol 2012;23(2):144-54
   PubMed Web of Science ®Google Scholar
• Huang C-C, Kuo H-C, Chu C-C, et al. Rapid visual recovery after coenzyme q10 treatment of leber hereditary optic neuropathy. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 2002;22(1):66
   PubMed Web of Science ®Google Scholar
• Kernt M, Arend N, Buerger A, et al. Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio. J Glaucoma 2013;22(5):404-12
   PubMed Web of Science ®Google Scholar
• Fiebiger SM, Bros H, Grobosch T, et al. The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse. J Neuroimmunol 2013;262(1-2):66-71
   PubMed Web of Science ®Google Scholar
• Sadun AA, Chicani CF, Ross-Cisneros FN, et al. Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch Neurol 2012;69(3):331-8
   PubMed Web of Science ®Google Scholar
• Lam BL, Feuer WJ, Schiffman JC, et al. Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy: preparation for gene therapy clinical trial. JAMA Ophthalmol 2014;132(4):428-36
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Ikeda Y, Yonemitsu Y, et al. Pigment epithelium-derived factor gene therapy targeting retinal ganglion cell injuries: neuroprotection against loss of function in two animal models. Hum Gene Ther 2011;22(5):559-65
   PubMed Web of Science ®Google Scholar
• Renwick J, Narang MA, Coupland SG, et al. XIAP-mediated neuroprotection in retinal ischemia. Gene Ther 2006;13(4):339-47
   PubMed Web of Science ®Google Scholar
• Mansergh FC, Chadderton N, Kenna PF, et al. Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy. Eur J Hum Genet EJHG 2014;22(11):1314-20
   PubMed Web of Science ®Google Scholar
• Hedayatpour A, Ragerdi I, Pasbakhsh P, et al. Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis. Cell J 2013;15(2):142-51
   PubMed Web of Science ®Google Scholar
• Jaramillo-Merchán J, Jones J, Ivorra JL, et al. Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model. Cell Death Dis 2013;4:e779
   PubMed Web of Science ®Google Scholar
• Johnson TV, Bull ND, Hunt DP, et al. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci 2010;51(4):2051-9
   PubMed Web of Science ®Google Scholar
• Johnson TV, Martin KR, Tomarev SI. Reply: platelet-derived growth factor-BB may be involved in mesenchymal stem cell secretome-induced neuroprotection of retinal ganglion cells. Brain J Neurol 2014;137(Pt 5):e277
   Google Scholar
• Dawson WW, Brooks DE, Hope GM, et al. Primary open angle glaucomas in the rhesus monkey. Br J Ophthalmol 1993;77:302-10
   PubMed Web of Science ®Google Scholar
• Kolker AE, Moses RA, Constant MA, et al. THE DEVELOPMENT OF GLAUCOMA IN RABBITS. Invest Ophthalmol 1963;2:316-21
   PubMedGoogle Scholar
• McLellan GJ, Betts DM, Sigle K, et al. Congenital glaucoma in the Siamese cat - a novel spontaneous animal model for glaucoma research. ARVO Meet Abstr 2005;46(5):134
   Google Scholar
• De Kater AW, Smyth JR, Rosenquist RC, et al. The Slate turkey: a model for secondary angle closure glaucoma. Invest Ophthalmol Vis Sci 1986;27(12):1751-4
   PubMed Web of Science ®Google Scholar
• Takatsuji K, Sato Y, Iizuka S, et al. Animal model of closed angle glaucoma in albino mutant quails. Invest Ophthalmol Vis Sci 1986;27(3):396-400
   PubMed Web of Science ®Google Scholar
• Gaasterland D, Tanishima T, Kuwabara T. Axoplasmic flow during chronic experimental glaucoma. Invest Ophthalmol Vis Sci 1978;17(9):838-46
   PubMed Web of Science ®Google Scholar
• Johnson B, House P, Morgan W, et al. Developing laser-induced glaucoma in rabbits. Aust N Z J Ophthalmol 1999;27(3-4):180-3
   PubMedGoogle Scholar
• Carelli V, La Morgia C, Sadun AA. Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options. Curr Opin Neurol 2013;26(1):52-8
   PubMed Web of Science ®Google Scholar
• Casson RJ, Chidlow G, Wood JPM, et al. Definition of glaucoma: clinical and experimental concepts. Clin Experiment Ophthalmol 2012;40(4):341-9
   PubMed Web of Science ®Google Scholar
• Gerometta R, Podos SM, Danias J, et al. Steroid-induced ocular hypertension in normal sheep. Invest Ophthalmol Vis Sci 2009;50(2):669-73
   PubMed Web of Science ®Google Scholar
• Gerometta R, Podos SM, Candia OA, et al. Steroid-induced ocular hypertension in normal cattle. Arch Ophthalmol 2004;122(10):1492-7
   PubMedGoogle Scholar
• Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. Production of elevated intraocular pressure by anterior chamber injection of autologous ghost red blood cells. Invest Ophthalmol Vis Sci 1980;19(2):126-36
   PubMed Web of Science ®Google Scholar
• Weber AJ, Zelenak D. Experimental glaucoma in the primate induced by latex microspheres. J Neurosci Methods 2001;111:39-48
   PubMed Web of Science ®Google Scholar
• Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol 1974;13(6):455-7
   PubMedGoogle Scholar
• Lauber JK. Light-induced avian glaucoma as an animal model for human primary glaucoma. J Ocul Pharmacol 1987;3(1):77-100
   PubMedGoogle Scholar
• Stujenske JM, Dowling JE, Emran F. The bugeye mutant zebrafish exhibits visual deficits that arise with the onset of an enlarged eye phenotype. Invest Ophthalmol Vis Sci 2011;52(7):4200-7
   PubMed Web of Science ®Google Scholar
• Chen C-C, Yeh L-K, Liu C-Y, et al. Morphological differences between the trabecular meshworks of zebrafish and mammals. Curr Eye Res 2008;33(1):59-72
   PubMed Web of Science ®Google Scholar
• Gray MP, Smith RS, Soules KA, et al. The aqueous humor outflow pathway of zebrafish. Invest Ophthalmol Vis Sci 2009;50(4):1515-21
   PubMed Web of Science ®Google Scholar
• Schuettauf F, Rejdak R, Walski M, et al. Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol (Berl) 2004;107(4):352-8
   PubMed Web of Science ®Google Scholar
• Libby RT, Smith RS, Savinova OV, et al. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 2003;299(5612):1578-81
   PubMed Web of Science ®Google Scholar
• Senatorov V, Malyukova I, Fariss R, et al. Expression of Mutated Mouse Myocilin Induces Open-Angle Glaucoma in Transgenic Mice. J Neurosci 2006;26(46):11903-14
   PubMed Web of Science ®Google Scholar
• Mabuchi F, Lindsey JD, Aihara M, et al. Optic nerve damage in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci 2004;45(6):1841-5
   PubMed Web of Science ®Google Scholar
• Harada T, Harada C, Nakamura K, et al. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 2007;117(7):1763-70
   PubMed Web of Science ®Google Scholar
• Wax MB, Tezel G, Yang J, et al. Induced Autoimmunity to Heat Shock Proteins Elicits Glaucomatous Loss of Retinal Ganglion Cell Neurons via Activated T Cell-Derived Fas-Ligand. J Neurosci Off J Soc Neurosci 2008;28(46):12085-96
   PubMed Web of Science ®Google Scholar
• Bettelli E, Baeten D, Jäger A, et al. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 2006;116(9):2393-402
   PubMed Web of Science ®Google Scholar
• Bernstein SL, Guo Y, Kelman SE, et al. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2003;44(10):4153-62
   PubMed Web of Science ®Google Scholar
• Chen CS, Johnson MA, Flower RA, et al. A primate model of nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2008;49(7):2985-92
   PubMed Web of Science ®Google Scholar
• Chuman H, Maekubo T, Osako T, et al. Rodent model of nonarteritic ischemic optic neuropathy and its electrophysiological evaluation. Jpn J Ophthalmol 2012;56(5):518-27
   PubMed Web of Science ®Google Scholar
• Yokota M, Shitara H, Hashizume O, et al. Generation of trans-mitochondrial mito-mice by the introduction of a pathogenic G13997A mtDNA from highly metastatic lung carcinoma cells. FEBS Lett 2010;584(18):3943-8
   PubMed Web of Science ®Google Scholar
• Alavi MV, Bette S, Schimpf S, et al. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain J Neurol 2007;130(Pt 4):1029-42
   Google Scholar
• Davies VJ, Hollins AJ, Piechota MJ, et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum Mol Genet 2007;16(11):1307-18
   PubMed Web of Science ®Google Scholar